Engineers Gate Manager’s Xeris Biopharma Holdings XERS Stock Holding History

Engineers Gate Manager’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Buy	185,911 +96,507	+108%	+$640K	0.01%	1006
2025 Q4	$702K	Sell	89,404 -20,590	-19%	-$162K	0.01%	1202
2025 Q3	$895K	Buy	109,994 +71,954	+189%	+$478K	0.01%	1205
2025 Q2	$178K	Buy	+38,040	New	+$174K	﹤0.01%	1918
2019 Q4	–	Sell	-20,264	Closed	-$199K	–	1869
2019 Q3	$199K	Buy	+20,264	New	+$228K	0.01%	1204
2019 Q2	–	Sell	-42,333	Closed	-$425K	–	1403
2019 Q1	$425K	Buy	+42,333	New	+$542K	0.03%	648

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Engineers Gate Manager's XERS Position: Q1 2026 in Review

Engineers Gate Manager increased its Xeris Biopharma Holdings (XERS) stake by 108% in Q1 2026, buying an estimated $640K and bringing the position to 185,911 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #1006.

Engineers Gate Manager first reported a position in XERS in Q1 2019 and has held it in 6 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Engineers Gate Manager held 185,911 shares of Xeris Biopharma Holdings worth $1.08M as of Q1 2026.
Engineers Gate Manager bought 96,507 Xeris Biopharma Holdings shares in Q1 2026, an estimated $640K.
Xeris Biopharma Holdings made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1006 holding.
Engineers Gate Manager first reported a position in Xeris Biopharma Holdings in Q1 2019 and has held it in 6 quarters since.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.